ask="3.50"
ask_size="600"
average_daily_volume="538848"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.08"
change_from_200_day_moving_average="1.33"
change_from_50_day_moving_average="0.91"
change_from_52_week_high="-0.35"
change_From_52_week_low="2.38"
change_in_percent="+2.41%"
close="3.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="20320000"
high="3.51"
high_52_weeks="3.75"
last_trade_date="3/8/2017"
last_trade_price="3.40"
last_trade_size="3101"
last_trade_time="4:00pm"
low="3.30"
low_52_weeks="1.02"
market_capitalization="79.72M"
moving_average_200_day="2.07"
moving_average_50_day="2.49"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="3.38"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+64.45%"
percent_change_from_50_day_moving_average="+36.38%"
percent_change_from_52_week_high="-9.33%"
percent_change_from_52_week_low="+233.33%"
previous_close="3.32"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.61"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.89"
stock_exchange="NCM"
symbol="CBAY"
volume="411903"
weeks_range_52="1.02 - 3.75"
